We present the Bladder Runner, a novel tool to enable detailed visual exploration and analysis of the impact of bladder shape variation on the accuracy of dose delivery, during the course of prostate cancer radiotherapy (RT). Our tool enables the investigation of individual patients and cohorts through the entire treatment process, and it can give indications of RT-induced complications for the patient. In prostate cancer RT treatment, despite the design of an initial plan prior to dose administration, bladder toxicity remains very common. The main reason is that the dose is delivered in multiple fractions over a period of weeks, during which, the anatomical variation of the bladder -due to differences in urinary filling -causes deviations between planned and delivered doses. Clinical researchers want to correlate bladder shape variations to dose deviations and toxicity risk through cohort studies, to understand which specific bladder shape characteristics are more prone to side effects. This is currently done with Dose-Volume Histograms (DVHs), which provide limited, qualitative insight. The effect of bladder variation on dose delivery and the resulting toxicity cannot be currently examined with the DVHs. To address this need, we designed and implemented the Bladder Runner, which incorporates visualization strategies in a highly interactive environment with multiple linked views. Individual patients can be explored and analyzed through the entire treatment period, while inter-patient and temporal exploration, analysis and comparison are also supported. We demonstrate the applicability of our presented tool with a usage scenario, employing a dataset of 29 patients followed through the course of the treatment, across 13 time points. We conducted an evaluation with three clinical researchers working on the investigation of RT-induced bladder toxicity. All participants agreed that Bladder Runner provides better understanding and new opportunities for the exploration and analysis of the involved cohort data.
Material engineers use interrupted in situ tensile testing to investigate the damage mechanisms in composite materials. For each subsequent scan, the load is incrementally increased until the specimen is completely fractured. During the interrupted in situ testing of glass fiber reinforced polymers (GFRPs) defects of four types are expected to appear: matrix fracture, fiber/matrix debonding, fiber pull-out, and fiber fracture. There is a growing demand for the detection and analysis of these defects among the material engineers. In this paper, we present a novel workflow for the detection, classification, and visual analysis of defects in GFRPs using interrupted in situ tensile tests in combination with X-ray Computed Tomography. The workflow is based on the automatic extraction of defects and fibers. We introduce the automatic Defect Classifier assigning the most suitable type to each defect based on its geometrical features. We present a visual analysis system that integrates four visualization methods: 1) the Defect Viewer highlights defects with visually encoded type in the context of the original CT image, 2) the Defect Density Maps provide an overview of the defect distributions according to type in 2D and 3D, 3) the Final Fracture Surface estimates the material fracture's location and displays it as a 3D surface, 4) the 3D Magic Lens enables interactive exploration by combining detailed visualizations in the region of interest with overview visualizations as context. In collaboration with material engineers, we evaluate our solution and demonstrate its practical applicability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.